Flow of participants in randomised studies

Medical Journal of Australia

Volumn 178, Issue 7, 2003, Pages 347-349

  Cakir, Burcu ^a   Gebski, Val J ^a   Keech, Anthony C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; FOLLOW UP; HUMAN; METHODOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SCREENING; SENSITIVITY ANALYSIS; SHORT SURVEY; STATISTICAL ANALYSIS; TREATMENT PLANNING;

EID: 0037425253     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05232.x     Document Type: Short Survey

References (5)

1. Moher D, Schulz K, Altman D. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomised trials. Lancet 2001; 357: 1191-1194.
2. Wing LMH, Reid CM, Ryan P, et al. for the Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-592.
3. Kirby A, Gebski VJ, Keech AC. Sample size in a clinical trial. Med J Aust 2002; 177: 256-257.
4. Beller EM, Gebski VJ, Keech AC. Randomisation in clinical trials. Med J Aust 2002; 177: 565-567.
5. Fisher LD, Dixon DO, Herson J, et al. Intention to treat in clinical trials. In: Peace KE, editor. Statistical Issues in Drug Research and Development. New York: Marcel Dekker; 1990.